Tomas Kozak

Head

Charles University

Czech Republic

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Lukáš Smolej

CZECH REPUBLIC

View details

Kristina Holubova

National Institute of Mental Health

CZECH REPUBLIC

View details

Michal Holesta

teaching assistant

Charles University Faculty of Medicine

CZECH REPUBLIC

View details

Jan Novak

CZECH REPUBLIC

View details

Lenka Kleteckova

National Institute of Mental Health

CZECH REPUBLIC

View details

Iveta Fajnerova

Senior researcher/Head of working group

National Institute of Mental Health

CZECH REPUBLIC

View details

Martin Špaček

General University Hospital in Prague

CZECH REPUBLIC

View details

Ondrej Havranek

Charles University

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomas Kozak

Research Interests

Explore related searches

Contact this professor

Articles (9)

Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions

Cognitive impairment associated with Hodgkin’s lymphoma and chemotherapy

Immune thrombocytopenia in a patient with essential thrombocythemia after SARS-CoV-2 infection: A case report

Circulating tumor DNA in Hodgkin lymphoma

Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.

Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.

Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement.

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Collaborators (8)

Lukáš Smolej

Kristina Holubova

Michal Holesta

Jan Novak

Lenka Kleteckova

Iveta Fajnerova

Martin Špaček

Ondrej Havranek

Make your next move.